Back
NM_024675.4:c.1058A>T
p.Lys353Ile · PALB2
0%
complete
Final classification
Uncertain Significance - Conflicting Evidence
PM2BP1
PALB2
c.1058A>T
p.Lys353Ile
This variant

The PALB2 c.1058A>T (p.Lys353Ile) variant has been reported in ClinVar as uncertain significance by a single submitter.

Transcript
NM_024675.4
HGVS · transcript:coding
NM_024675.4:c.1058A>T
GRCh38
chr16:23635488 T>A
GRCh37
chr16:23646809 T>A
Richards et.al., 2015 - Combining rules v1.2.0 criteria-combination framework: matched Rule31 (Benign.Supporting >=1 + Pathogenic.Supporting >=1) with applied criteria: BP1 supporting, PM2 supporting; maps to Uncertain Significance - Conflicting Evidence.
Classification rationale
PM2 BP1 Uncertain Significance - Conflicting Evidence
PALB2 c.1058A>T

The PALB2 c.1058A>T (p.Lys353Ile) variant has been reported in ClinVar as uncertain significance by a single submitter.1 This variant is absent from gnomAD v2.1 and gnomAD v4.1, and its gnomAD v4.1 allele frequency is therefore below the PALB2 PM2_Supporting threshold of 0.000333%.2 PALB2-specific rules support BP1 for this missense variant, while SpliceAI predicts no significant splice impact with a maximum delta score of 0.00 and PVS1, PP3, and BP4 are not applied in this missense setting.3

PM2 + BP1 Uncertain Significance - Conflicting Evidence
LYFE Sciences is an AI system, and it can make mistakes. Criteria may be applied incorrectly, sources may be misread, and a confident-looking classification can still be wrong. Double-check every criterion and its underlying evidence before relying on any call.
Gene diagram · NM_024675.4 · variants mapped to exon structure
PALB2 NM_024675.4
Fetching transcript structure from UCSC…
Applied criteria · 2 applied · 7 assessed
MetEvidence satisfies this criterion.
Not metEvaluated against available evidence; threshold not reached.
Not assessedApplies in principle, but no evidence was found to evaluate it.
N/ADoesn't apply to this variant type.
Applied · 2
Strength Supporting Moderate Strong Very strong
PM2 supporting review Pathogenic
This variant is absent from gnomAD v4.1 and gnomAD v2.1. The observed gnomAD v4.1 allele frequency is 0%, which is below the PALB2 PM2_Supporting threshold of ≤0.000333%, so PM2_Supporting is met.
gnomAD v4.1: absentgnomAD v2.1: absentPALB2 PM2_Supporting threshold: frequency ≤1/300
BP1 supporting review Benign
This variant is a missense substitution, and the PALB2 VCEP applies BP1 to all missense variants because truncating variants are the predominant established disease mechanism for this gene.
NM_024675.4:c.1058A>T causes p.(Lys353Ile)a missense changePALB2 VCEP BP1 rule: apply to all missense variants
Assessed · not applied · 2 not met · 5 not assessed
Pathogenic
PS4 This variant has been reported in ClinVar as uncertain significance by a single submitter, but no case-control study data, odds ratio, relative risk, or qualifying statistical enrichment data were identified; PS4 cannot be assessed.
PM3 No data were identified showing this variant in trans with a pathogenic PALB2 variant in an affected individual with Fanconi anemia, so PM3 cannot be assessed.
PP1 No family segregation data or quantitative LOD/Bayes factor evidence were identified to show co-segregation with disease, so PP1 cannot be assessed.
Benign
BA1 This variant is absent from gnomAD v4.1, so the observed allele frequency is 0%, which is below the PALB2 BA1 threshold of >0.1%; BA1 is not met.
BS1 This variant is absent from gnomAD v4.1, so the observed allele frequency is 0%, which is below the PALB2 BS1 threshold of >0.01%; BS1 is not met.
BS2 No data were identified showing this variant in unaffected individuals under the PALB2 BS2 point-based framework, so BS2 cannot be assessed.
BS4 No segregation study data or quantitative LOD/Bayes factor evidence were identified to show lack of segregation with disease, so BS4 cannot be assessed.
N/A · 19 PVS1 · PS1 · PS2 · PS3 · PM1 · PM4 · PM5 · PM6 · PP2 · PP3 · PP4 · PP5 · BS3 · BP2 · BP3 · BP4 · BP5 · BP6 · BP7
Research & evidence
Population frequency
gnomAD v4.1 screenshot
gnomAD v4.1
gnomAD v2.1 screenshot
gnomAD v2.1
v4.1
Absent from gnomAD v4.1.
v2.1
Absent from gnomAD v2.1.
Allele frequency by ancestry
three datasets · side by side
gnomAD v4.1
Absent · 0 / ?
0 hom
Not observed in any ancestry group.
gnomAD v2.1
Absent · 0 / ?
0 hom
Not observed in any ancestry group.
ClinVar screenshot
ClinVar
This variant has been reported in ClinVar as Uncertain significance (1 clinical laboratory).
SpliceAI screenshot
In silico
SpliceAI predicts no significant splice impact for this variant (max delta score = 0.00). REVEL score = 0.086. BayesDel score = -0.4788.
Functional / OncoKB screenshot
Functional Unknown Oncogenic Effect
OncoKB has not reviewed this specific variant; no variant-level oncogenicity or biological effect is available. Gene-level context: PALB2, a scaffolding protein involved in DNA repair, is altered in various cancers.
OncoKB ↗
COSMIC screenshot
COSMIC
Cancer hotspots screenshot
Cancer hotspots
Somatic evidence Not in COSMIC / hotspots
COSMIC
This variant does not lie in a statistically significant hotspot. This variant has not previously been reported in somatic cancers (COSMIC).
Hotspots
This variant does not lie in a statistically significant hotspot.
Sources & reference links
8Sources
CSpec VCEP
ClinVar
gnomAD v2.1
gnomAD v4.1
SpliceAI
OncoKB
COSMIC
Cancer hotspots